Evidence map›Paper›PMID 27847355›Full record

ArticleJournal of virology2017

Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.

Jessica F Bruhn, Robert N Kirchdoerfer, Sarah M Urata, Sheng Li, Ian J Tickle, Gérard Bricogne, Erica Ollmann Saphire

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. 25 Years of Ebola Virus VP35 Research.Journal of molecular biology · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Structural and biophysical characterization of the Borna disease virus 1 phosphoprotein.Acta crystallographica. Section F, Structural biology communications · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Structures of theJournal of virology · 2020
    Review
  18. Targeting the Respiratory Syncytial Virus NAntimicrobial agents and chemotherapy · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jessica F BruhnDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Robert N KirchdoerferDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Sarah M UrataDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Sheng LiDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Ian J TickleGlobal Phasing Ltd., Cambridge, United Kingdom.
Gérard BricogneGlobal Phasing Ltd., Cambridge, United Kingdom.
Erica Ollmann SaphireDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA erica@scripps.edu.
Scripps Research Institute · USGlobal Phasing (United Kingdom) · GBUniversity of California, San Diego · US

Funding

X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
Structure based design of antibodies and vaccinesU19AI117905 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SCHIEF, WILLIAM R. · 2015 to 2019
$12.0M
ACTION OF LIPOLYTIC ENZYMESR01GM020501 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 1985 to 2020
$7.3M
Mechanism of receptor-mediated entry and infection by filovirusesR01AI101436 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI CHANDRAN, KARTIK · 2012 to 2016
$4.0M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007606 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1999 to 2013
$2.1M
Function and assembly of the Ebola virus nucleocapsidR01AI118016 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SAPHIRE, ERICA OLLMANN · 2016 to 2019
$2.0M
NIAID NIH HHS R01 AI101436NIAID NIH HHS R01 AI118016NIAID NIH HHS T32 AI007606NIAID NIH HHS U19 AI117905NIGMS NIH HHS P41 GM103393NIGMS NIH HHS R01 GM020501
6 · The paper itself

Abstract

Marburg virus (MARV) is a highly pathogenic filovirus that is classified in a genus distinct from that of Ebola virus (EBOV) (genera Marburgvirus and Ebolavirus, respectively). Both viruses produce a multifunctional protein termed VP35, which acts as a polymerase cofactor, a viral protein chaperone, and an antagonist of the innate immune response. VP35 contains a central oligomerization domain with a predicted coiled-coil motif. This domain has been shown to be essential for RNA polymerase function. Here we present crystal structures of the MARV VP35 oligomerization domain. These structures and accompanying biophysical characterization suggest that MARV VP35 is a trimer. In contrast, EBOV VP35 is likely a tetramer in solution. Differences in the oligomeric state of this protein may explain mechanistic differences in replication and immune evasion observed for MARV and EBOV. IMPORTANCE: Marburg virus can cause severe disease, with up to 90% human lethality. Its genome is concise, only producing seven proteins. One of the proteins, VP35, is essential for replication of the viral genome and for evasion of host immune responses. VP35 oligomerizes (self-assembles) in order to function, yet the structure by which it assembles has not been visualized. Here we present two crystal structures of this oligomerization domain. In both structures, three copies of VP35 twist about each other to form a coiled coil. This trimeric assembly is in contrast to tetrameric predictions for VP35 of Ebola virus and to known structures of homologous proteins in the measles, mumps, and Nipah viruses. Distinct oligomeric states of the Marburg and Ebola virus VP35 proteins may explain differences between them in polymerase function and immune evasion. These findings may provide a more accurate understanding of the mechanisms governing VP35's functions and inform the design of therapeutics.

Indexed as

Models, MolecularProtein ConformationProtein Interaction Domains and MotifsProtein MultimerizationAmino Acid SequenceCrystallography, X-RayHydrophobic and Hydrophilic InteractionsMarburgvirusProtein BindingProtein StabilityThermodynamicsViral Regulatory and Accessory ProteinsViral Regulatory and Accessory ProteinsVP35 protein, filoviruscoiled coilEbola virusfilovirusMarburg virusoligomerizationphosphoproteinRNA-dependent RNA polymeraseVP35X-ray crystallography

Identifiers

PMID27847355
PMCPMC5215338
OpenAlexW2552680141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.